GIMV Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, GIMV has acquired 5 companies. It has also invested in 12 others.

GIMV’s most common sectors for investment arelife science (16%) and software (9%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (32%) and venture (25%). In total, GIMV has invested in 4 US states and 11 different countries. Its largest (disclosed) acquisition occurred in 2010 when it acquired OneDirect SAS for $15M.

In the last 3 years, GIMV has exited 6 companies. The Firm’s most common exit type is trade sale (51%). GIMV’s largest (disclosed) exit occurred in 2013 when it sold Astex Pharmaceuticals for $886M.

Join Mergr to view GIMV’s full profile and discover more large private equity firm investors just like it.

M&A Summary

M&A Total Activity252
- M&A Buy Activity155
- M&A Sell Activity97
Total Sectors Invested 44
Total Countries Invested 11
M&A Buy/Sell Connections 76
M&A Advisors 2

GIMV

Karel Oomsstraat 37,
Antwerp, B-2018
Belgium
+32 3 290.21.00
www.gimv.com
info@gimv.com

Transaction Criteria	Min	Max
Target Revenue	15	150
Target EBITDA	-	-
Investment Size	5	75
Enterprise Value	-	-
values in millions of EUR

Transaction Criteria

Min

Max

Target Revenue

150

Target EBITDA

Investment Size

Enterprise Value

values in millions of EUR

Year	≤ '19	'20	'21	'22	'23	'24	T
Buy (4.6/yr)	#	132	6	7	9	1	-	155
vol	$15M						$15M
Sell (1.8/yr)	#	88	3	2	4	-	-	97
vol	$3.4B						$3.4B
	252

Year

≤ '19

'20

'21

'22

'23

'24

Buy (4.6/yr)

132

155

vol

$15M

Sell (1.8/yr)

vol

$3.4B

252

Company	Date	Value	Type
Witec Group	2023-04-25	-	Buyout (LBO, MBO, MBI)
Stadskanaal, Netherlands · www.witec.nl
Biolam Group	2022-12-09	-	Secondary Sale
Amiens, France · www.groupebiolam.fr
Eurocept Group	2022-07-13	-	Sold to Management
Houten, Netherlands · www.eurocept.nl
Lenaerts NV	2022-07-12	-	Growth Capital
Houthalen-Helchteren, Belgium · www.lenaertsnv.be
ABN NV	2022-07-12	-	Growth Capital
Munsterbilzen, Belgium · www.abn.be
Dirickx Industries	2022-06-09	-	Stake Purchase
Congrier, France · www.dirickx.com
ImmunOs Therapeutics AG	2022-06-07	-	Venture
Zurich, Switzerland · www.immunostherapeutics.com
Variotech GmbH	2022-05-24	-	Growth Capital
Nordhorn, Germany · www.variotech.de
Variass Group B.V.	2022-05-18	-	Growth Capital
Veendam, Netherlands · www.variass.nl
BioConnection B.V.	2022-04-22	-	Growth Capital
Oss, Netherlands · www.bioconnection.eu
View All >>

Company

Date

Value

Type

Witec Group

2023-04-25

Buyout (LBO, MBO, MBI)

Stadskanaal, Netherlands · www.witec.nl

Biolam Group

2022-12-09

Secondary Sale

Amiens, France · www.groupebiolam.fr

Eurocept Group

2022-07-13

Sold to Management

Houten, Netherlands · www.eurocept.nl

Lenaerts NV

2022-07-12

Growth Capital

Houthalen-Helchteren, Belgium · www.lenaertsnv.be

ABN NV

2022-07-12

Growth Capital

Munsterbilzen, Belgium · www.abn.be

Dirickx Industries

2022-06-09

Stake Purchase

Congrier, France · www.dirickx.com

ImmunOs Therapeutics AG

2022-06-07

Venture

Zurich, Switzerland · www.immunostherapeutics.com

Variotech GmbH

2022-05-24

Growth Capital

Nordhorn, Germany · www.variotech.de

Variass Group B.V.

2022-05-18

Growth Capital

Veendam, Netherlands · www.variass.nl

BioConnection B.V.

2022-04-22

Growth Capital

Oss, Netherlands · www.bioconnection.eu

View All >>

Sector	Current #	Value	All-time #	Value
Life Science	11 (18%)	-	24 (15%)	-
Software	2 (3%)	-	14 (9%)	-
Business Services	5 (8%)	-	11 (7%)	-
Information Technology	3 (5%)	-	8 (5%)	-
Medical Products	5 (8%)	-	8 (5%)	-
Food	2 (3%)	-	7 (4%)	-
Healthcare Services	3 (5%)	-	7 (4%)	-
Consumer Products	3 (5%)	-	6 (4%)	-
Electrical Equipment	4 (6%)	-	6 (4%)	-
Automotive	3 (5%)	-	5 (3%)	-
Machinery	-	-	5 (3%)	-
Distribution	1 (2%)	-	4 (3%)	15M (100%)
Building Materials	-	-	4 (3%)	-
Chemicals	1 (2%)	-	4 (3%)	-
Manufacturing	2 (3%)	-	4 (3%)	-
Apparel/Textiles	1 (2%)	-	3 (2%)	-
Electronics	3 (5%)	-	3 (2%)	-
E-Commerce	-	-	2 (1%)	-
Marketing	1 (2%)	-	2 (1%)	-
Restaurants	2 (3%)	-	2 (1%)	-
Safety/Security	2 (3%)	-	2 (1%)	-
Semiconductors	-	-	2 (1%)	-
Staffing	1 (2%)	-	2 (1%)	-
Agriculture	-	-	1 (1%)	-
Beverages	1 (2%)	-	1 (1%)	-
Communications	1 (2%)	-	1 (1%)	-
Construction	1 (2%)	-	1 (1%)	-
Consumer Services	1 (2%)	-	1 (1%)	-
Diversified	-	-	1 (1%)	-
Education	-	-	1 (1%)	-
Environmental	-	-	1 (1%)	-
Forest Products	-	-	1 (1%)	-
Information Services	-	-	1 (1%)	-
Insurance	-	-	1 (1%)	-
Internet Software and Services	1 (2%)	-	1 (1%)	-
Leisure	1 (2%)	-	1 (1%)	-
Media	-	-	1 (1%)	-
Oil/Gas Exploration	-	-	1 (1%)	-
Publishing	-	-	1 (1%)	-
Renewable Energy	-	-	1 (1%)	-
Retail	-	-	1 (1%)	-
Technology Hardware	-	-	1 (1%)	-
Test/Measurement Equipment	1 (2%)	-	1 (1%)	-
Utilities	-	-	1 (1%)	-
Total	62	-	156	$15M

Sector

Current #

Value

All-time #

Value

Life Science

11 (18%)

24 (15%)

Software

2 (3%)

14 (9%)

Business Services

5 (8%)

11 (7%)

Information Technology

3 (5%)

8 (5%)

Medical Products

5 (8%)

8 (5%)

Food

2 (3%)

7 (4%)

Healthcare Services

3 (5%)

7 (4%)

Consumer Products

3 (5%)

6 (4%)

Electrical Equipment

4 (6%)

6 (4%)

Automotive

3 (5%)

5 (3%)

Machinery

5 (3%)

Distribution

1 (2%)

4 (3%)

15M (100%)

Building Materials

4 (3%)

Chemicals

1 (2%)

4 (3%)

Manufacturing

2 (3%)

4 (3%)

Apparel/Textiles

1 (2%)

3 (2%)

Electronics

3 (5%)

3 (2%)

E-Commerce

2 (1%)

Marketing

1 (2%)

2 (1%)

Restaurants

2 (3%)

2 (1%)

Safety/Security

2 (3%)

2 (1%)

Semiconductors

2 (1%)

Staffing

1 (2%)

2 (1%)

Agriculture

1 (1%)

Beverages

1 (2%)

1 (1%)

Communications

1 (2%)

1 (1%)

Construction

1 (2%)

1 (1%)

Consumer Services

1 (2%)

1 (1%)

Diversified

1 (1%)

Education

1 (1%)

Environmental

1 (1%)

Forest Products

1 (1%)

Information Services

1 (1%)

Insurance

1 (1%)

Internet Software and Services

1 (2%)

1 (1%)

Leisure

1 (2%)

1 (1%)

Media

1 (1%)

Oil/Gas Exploration

1 (1%)

Publishing

1 (1%)

Renewable Energy

1 (1%)

Retail

1 (1%)

Technology Hardware

1 (1%)

Test/Measurement Equipment

1 (2%)

1 (1%)

Utilities

1 (1%)

Total

156

$15M

State/Country	Current #	Value	All-time #	Value
Belgium	13 (21%)	-	45 (29%)	-
Netherlands	14 (23%)	-	40 (26%)	-
France	13 (21%)	-	30 (19%)	15M (100%)
Germany	13 (21%)	-	18 (12%)	-
United States	3 (5%)	-	8 (5%)	-
	Massachusetts	1 (2%)	-	3 (2%)	-
	California	1 (2%)	-	3 (2%)	-
	New York	1 (2%)	-	1 (1%)	-
	Pennsylvania	-	-	1 (1%)	-
Switzerland	3 (5%)	-	5 (3%)	-
United Kingdom	-	-	4 (3%)	-
Ireland	3 (5%)	-	3 (2%)	-
Spain	-	-	1 (1%)	-
Israel	-	-	1 (1%)	-
Russia	-	-	1 (1%)	-
Domestic	13 (21%)	-	45 (29%)	-
Cross-border	49 (79%)	-	111 (71%)	15M (100%)
Total	62	-	156	$15M

State/Country

Current #

Value

All-time #

Value

Belgium

13 (21%)

45 (29%)

Netherlands

14 (23%)

40 (26%)

France

13 (21%)

30 (19%)

15M (100%)

Germany

13 (21%)

18 (12%)

United States

3 (5%)

8 (5%)

Massachusetts

1 (2%)

3 (2%)

California

1 (2%)

3 (2%)

New York

1 (2%)

1 (1%)

Pennsylvania

1 (1%)

Switzerland

3 (5%)

5 (3%)

United Kingdom

4 (3%)

Ireland

3 (5%)

3 (2%)

Spain

1 (1%)

Israel

1 (1%)

Russia

1 (1%)

Domestic

13 (21%)

45 (29%)

Cross-border

49 (79%)

111 (71%)

15M (100%)

Total

156

$15M

Type	Current #	Value	All-time #	Value
Buyout (LBO, MBO, MBI)	12 (19%)	-	49 (31%)	15M (100%)
Venture	14 (23%)	-	39 (25%)	-
Growth Capital	18 (29%)	-	30 (19%)	-
Secondary Buyout	10 (16%)	-	24 (15%)	-
Stake Purchase	6 (10%)	-	10 (6%)	-
Divestiture	1 (2%)	-	2 (1%)	-
Consolidation	1 (2%)	-	1 (1%)	-
Going Private	-	-	1 (1%)	-
Total	62	-	156	$15M

Type

Current #

Value

All-time #

Value

Buyout (LBO, MBO, MBI)

12 (19%)

49 (31%)

15M (100%)

Venture

14 (23%)

39 (25%)

Growth Capital

18 (29%)

30 (19%)

Secondary Buyout

10 (16%)

24 (15%)

Stake Purchase

6 (10%)

10 (6%)

Divestiture

1 (2%)

2 (1%)

Consolidation

1 (2%)

1 (1%)

Going Private

1 (1%)

Total

156

$15M

Type	Total #	Value
Trade Sale	30 (31%)	1.3B (37%)
Secondary Sale	25 (26%)	-
Trade Sale - Public Company	24 (25%)	2.1B (63%)
IPO	5 (5%)	-
Stake Sale	4 (4%)	-
Sold to Management	3 (3%)	-
Divestiture	2 (2%)	-
Merger	2 (2%)	-
Bankruptcy	1 (1%)	-
Unknown	1 (1%)	-
Total	97	$3.4B

Type

Total #

Value

Trade Sale

30 (31%)

1.3B (37%)

Secondary Sale

25 (26%)

Trade Sale - Public Company

24 (25%)

2.1B (63%)

IPO

5 (5%)

Stake Sale

4 (4%)

Sold to Management

3 (3%)

Divestiture

2 (2%)

Merger

2 (2%)

Bankruptcy

1 (1%)

Unknown

1 (1%)

Total

$3.4B

Financial	Deals
Lincoln International	1

Financial

Deals

Lincoln International

Legal	Deals
Dechert	1

Legal

Deals

Dechert

buy	#	Total
< $100M	1	$15M
TOTAL	$15M
Largest	OneDirect SAS $15M (2010-09-03)

buy

Total

< $100M

$15M

TOTAL

$15M

Largest

OneDirect SAS
$15M (2010-09-03)

sell	#	Total
$100M to $1B	8	$3.2B
< $100M	4	$247M
TOTAL	$3.4B
Largest	Astex Pharmaceuticals, Inc. $886M (2013-09-05)

sell

Total

$100M to $1B

$3.2B

< $100M

$247M

TOTAL

$3.4B

Largest

Astex Pharmaceuticals, Inc.
$886M (2013-09-05)

		Deals
Acquired from
Investor(s)	15%	24 (15%)
Strategic(s)	1%	2 (1%)
Exited to
Investor(s)	28%	27 (28%)
Strategic(s)	56%	54 (56%)

Deals

Acquired from

Investor(s)

24 (15%)

Strategic(s)

2 (1%)

Exited to

Investor(s)

27 (28%)

Strategic(s)

54 (56%)

FAQ

When was GIMV founded?

GIMV was founded in 1980.

What type of investor is GIMV?

GIMV is a private equity firm.

Where is GIMV headquartered?

GIMV is headquartered in Antwerp, Belgium.

How much capital does GIMV have under management?

GIMV has 2.0B EUR under management.

GIMV Mergers and Acquisitions Summary

Private Equity Firm Profile

M&A Summary

GIMV

Investment Criteria

M&A Summary

Buy vs Sell

Most Recent M&A

M&A by Sector

Acquisitions By Geo

Acquisitions by Deal Type

Exits by Deal Type

Top M&A Advisors

Deal Values

M&A Connections

Investor Summary

Investor Type

Size

PE Assets

Established

Specialist/Generalist

Leadership

Alex Behaeghe

Andreas Jurgeit

Boris Wirtz

Maja Markovic

Nick Medaer

FAQ

When was GIMV founded?

What type of investor is GIMV?

Where is GIMV headquartered?

How much capital does GIMV have under management?

Subscribe to unlock this and 201,152 investor and company profiles

Sign-up today to get full access

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Search

Ready to try?

Product

Company

Legal

Subscribe to unlock this and 201,152
investor and company profiles